Top Marijuana Stocks on the NASDAQ
Atlantic Alliance Partnership Corp. is a blank check company
that is currently in a merger agreement with Kalyx Development Inc. Kalyx is a leading real estate investment trust in the regulated cannabis industry in the U. S.
Recently, Nasdaq approved the continued listing of Atlantic Alliance Partnership Corp. while aware of their agreement with Kalyx.
Their pipeline currently includes two drugs being developed for indications including epilepsy,
osteoarthritis, fibromyalgia, peripheral neuropathic pain, and Fragile X syndrome.
Find the best broker for your trading or investing needs
Although the majority of U. S.-based cannabis companies
and many foreign ADRs trade over-the-counter, a few marijuana companies are traded on the NASDAQ.
GW Pharmaceuticals is developing a portfolio of cannabinoid medicines, including Sativex for the treatment of spasticity related to multiple sclerosis
and cancer pain, and Epidiolex for the treatment of childhood epilepsy.
Epidiolex is currently in phase three trials for Dravet Syndrome
and Lennox-Gastaut Syndrome, two forms of severe, early onset epilepsy without good existing treatment options.
Cara Therapeutics is a clinical-stage biotechnology company focused on developing
and commercializing new chemical entities for the indications of pain and pruritus (itching).